These studies report inflammatory effects of serum CXCL12 in various disease states (57, 58), to include malignancy (59), and that the CXCL12/CXCR4 mechanism may be directly involved in renal carcinoma (59). This evidence concerns the gene CXCR4 and renal carcinoma.